Atrial Flutter Workup
- Author: Lawrence Rosenthal, MD, PhD, FACC, FHRS; Chief Editor: Jeffrey N Rottman, MD more...
Approach Considerations
Electrocardiography (ECG) is essential in making the diagnosis. Transthoracic echocardiography is the preferred modality for evaluating atrial flutter.
The history and physical examination findings guide laboratory studies. Although hyperthyroidism is a rare cause of atrial flutter, asymptomatic hyperthyroidism, especially in elderly patients, can manifest as atrial fibrillation or flutter and should be excluded with thyroid function studies.
Obtain a complete blood count if anemia is suspected or the patient has a history of recent or current blood loss associated with presenting symptoms. Serum electrolytes and pulmonary function tests may be indicated based on the history. Obtain serum electrolyte and digoxin levels if appropriate.
Consider obtaining blood gas measurements in patients with hypoxia or carbon monoxide intoxication. Also, seek a history of stimulant drug usage (eg, ginseng, cocaine, ephedra, methamphetamine).
Chest radiography may be useful in evaluation of lung disease and the pulmonary vasculature. Chest radiographic findings are usually normal in patients with atrial flutter, but radiographic evidence of pulmonary edema may be present in subacute cases.
Electrocardiography
In the common form of type I atrial flutter, the ECG shows sawtooth flutter (F) waves. Flutter waves are often visualized best in leads II, III, aVF, or V1 (see the image below). The flutter waves for typical (type I) atrial flutter are inverted (negative) in these leads because of a counterclockwise re-entrant pathway. Sometimes, they are upright (positive) when the re-entrant loop is clockwise. Flutter waves (particularly 2:1) can deform the ST complex in such a manner as to mimic an ischemic injury pattern on the 12-lead ECG.
Twelve-lead ECG of type I atrial flutter. Note negative sawtooth pattern of flutter waves in leads II, III, and aVF. In typical (ie, type I) atrial flutter, the atrial rate is usually 250-350 beats per minute. The ventricular response may be regular or irregular. In patients with typical (ie, type I) atrial flutter, class IA and IC antiarrhythmic drugs and amiodarone can reduce the rate to approximately 200 beats per minute. If this occurs, the ventricles can respond in a 1:1 fashion to the slower atrial rate. The rate in atypical (ie, type II) flutter is 350-450 beats per minute.
The ventricular rate is a fixed mathematical relationship of flutter waves and the resulting QRS complexes. Variable AV conduction can also be seen (commonly present with 2:1 or 3:1 AV conduction). With 1:1 AV conduction, hemodynamic collapse may occur.
Deterioration to 1:1 conduction is a particular risk in patients with a preexcitation syndrome (Wolff-Parkinson-White). An ECG clue to a preexcitation syndrome is a very short PR interval (< .115s) and no delta wave.
Morphology of the flutter wave can predict findings in the electrophysiology laboratory. A negative flutter wave in the inferior limb leads and a positive flutter wave in V1 are highly predictive of a counterclockwise circuit; however, with positive flutter waves in the inferior limb leads and negative flutter waves in V1, differentiating between clockwise type I atrial flutter and atypical forms of non–isthmus-dependent intra-atrial reentry is difficult.
Flutter and fibrillation often coexist with alternating patterns (ie, fib-flutter, flitter) in the same tracing.
Diagnostic Aids
Vagal maneuvers can be helpful in determining the underlying atrial rhythm if flutter waves are not seen well.
Adenosine, administered in an intravenous push followed with an intravenous bolus with flush, can also be helpful in making the diagnosis of atrial flutter by transiently blocking the AV node (see the image below).
Type I atrial flutter unmasked by adenosine (Adenocard). Exercise testing can be utilized to identify exercise-induced atrial fibrillation and to evaluate ischemic heart disease.
A Holter monitor can be used to help identify arrhythmias in patients with nonspecific symptoms, identify triggers, and detect associated atrial arrhythmias.
Echocardiography
Transthoracic echocardiography is the preferred modality for evaluating atrial flutter. It can evaluate right and left atrial size, as well as the size and function of the right and left ventricles, which assists in diagnosing valvular heart disease, left ventricular hypertrophy (LVH), and pericardial disease.
Transthoracic echocardiography has low sensitivity for intra-atrial thrombi. Transesophageal echocardiography is the preferred technique to detect thrombus in the left atrium.
Suda K, Matsumura M, Hayashi Y. Myotonic dystrophy presenting as atrial flutter in childhood. Cardiol Young. Feb 2004;14(1):89-92. [Medline].
Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. Dec 2000;36(7):2242-6. [Medline].
Ghali WA, Wasil BI, Brant R, Exner DV, Cornuz J. Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis. Am J Med. Feb 2005;118(2):101-7. [Medline].
Bohnen M, Stevenson WG, Tedrow UB, et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. Nov 2011;8(11):1661-6. [Medline].
Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA. Risk of stroke in patients with atrial flutter. Am J Cardiol. Feb 1 2001;87(3):346-9, A9. [Medline].
Melsen WG, Rovers MM, Bonten MJ. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med. Oct 2009;37(10):2709-18. [Medline].
Aliot E, Denjoy I. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group. Am J Cardiol. Jan 25 1996;77(3):66A-71A. [Medline].
Falk RH, Pollak A, Singh SN, Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol. Feb 1997;29(2):385-90. [Medline].
Abi-Mansour P, Carberry PA, McCowan RJ, Henthorn RW, Dunn GH, Perry KT. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. Am Heart J. Oct 1998;136(4 Pt 1):632-42. [Medline].
Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. Oct 1 1996;94(7):1613-21. [Medline].
Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation. Dec 16 1997;96(12):4298-306. [Medline].
Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart. Jun 1998;79(6):568-75. [Medline]. [Full Text].
Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart. Jun 1998;79(6):568-75. [Medline]. [Full Text].
Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol. Dec 15 1998;82(12):1545-7, A8. [Medline].
Grimm RA, Stewart WJ, Arheart K, Thomas JD, Klein AL. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol. Mar 1 1997;29(3):582-9. [Medline].

